Also trades as: 2784.T (JPX) · $vol 7M · ARHCF (OTC) · $vol 0M

$13.55

+0.00 (+0.00%)

OTC · Healthcare · Medical - Distribution · Tech Score Sell · Power 47 · $2.5B mcap · 167M float · 0.0001% daily turnover · Short 45% of daily vol

Revenue

$3.29T +11.2% ▲

5Y CAGR: +4.8%

Gross Profit

$231.0B +8.0% ▲

5Y CAGR: +5.6%

Operating Income

$38.2B +0.3% ▲

5Y CAGR: +13.1%

Net Income

$44.3B +61.6% ▲

5Y CAGR: +12.6%

EPS (Diluted)

$242.87 +64.6% ▲

5Y CAGR: +16.0%

EBITDA

$54.1B -0.8% ▼

5Y CAGR: +10.7%

View Full Income Statement

Line Item	FY2022	FY2023	FY2024	FY2025	FY2026
Revenue	$2.59T	$2.70T	$2.86T	$2.96T	$3.29T
YoY Growth	-0.7%	+4.3%	+6.0%	+3.6%	+11.2%
Cost of Revenue	$2.40T	$2.50T	$2.65T	$2.75T	$3.06T
Gross Profit	$187.5B	$192.1B	$206.4B	$213.9B	$231.0B
Gross Margin	7.3%	7.1%	7.2%	7.2%	7.0%
R&D Expenses	$1.4B	$2.1B	$2.2B	$0	$0
SG&A Expenses	$149.2B	$152.1B	$157.9B	$175.8B	$192.8B
Operating Expenses	$158.4B	$161.9B	$167.9B	$175.8B	$192.8B
Operating Income	$29.1B	$30.1B	$38.5B	$38.1B	$38.2B
Operating Margin	1.1%	1.1%	1.3%	1.3%	1.2%
Interest Expense	$73M	$64M	$132M	$279M	$375M
Income Before Tax	$48.2B	$38.6B	$43.8B	$39.4B	$65.7B
Tax Expense	$16.0B	$12.8B	$14.2B	$11.9B	$21.4B
Net Income	$32.2B	$25.8B	$29.6B	$27.4B	$44.3B
Net Margin	1.2%	1.0%	1.0%	0.9%	1.3%
EPS (Diluted)	$153.57	$127.42	$154.13	$147.54	$242.87
EBITDA	$41.9B	$43.5B	$57.4B	$54.6B	$54.1B
Shares Outstanding	210M	202M	192M	186M	182M

Line Item	FY2025 Q1	FY2025 Q2	FY2025 Q3	FY2025 Q4	FY2026 Q1	FY2026 Q2	FY2026 Q3	FY2026 Q4
Revenue	$722.4B	$734.0B	$806.0B	$698.7B	$758.1B	$785.1B	$848.4B	$754.6B
Cost of Revenue	$671.9B	$682.1B	$745.6B	$647.5B	$706.3B	$730.2B	$787.9B	$700.9B
Gross Profit	$50.4B	$51.9B	$60.4B	$51.2B	$51.8B	$54.9B	$60.5B	$53.7B
Gross Margin	7.0%	7.1%	7.5%	7.3%	6.8%	7.0%	7.1%	7.1%
R&D Expenses	$0	$0	$0	$1.9B	$0	$0	$0	$0
SG&A Expenses	$43.7B	$43.6B	$44.3B	$44.3B	$44.9B	$45.5B	$46.7B	$47.2B
Operating Expenses	$43.7B	$43.6B	$44.3B	$44.3B	$44.9B	$45.5B	$46.7B	$47.2B
Operating Income	$6.7B	$8.3B	$16.2B	$6.9B	$7.0B	$9.4B	$13.8B	$6.6B
Operating Margin	0.9%	1.1%	2.0%	1.0%	0.9%	1.2%	1.6%	0.9%
Interest Expense	$69M	$75M	$78M	$57M	$85M	$91M	$88M	$96M
Income Before Tax	$6.9B	$13.7B	$17.0B	$1.7B	$7.6B	$10.4B	$30.0B	$15.0B
Tax Expense	$2.5B	$4.4B	$5.3B	-$264M	$2.6B	$3.7B	$9.1B	$5.1B
Net Income	$4.4B	$9.6B	$11.7B	$1.7B	$5.0B	$6.6B	$20.8B	$9.9B
Net Margin	0.6%	1.3%	1.4%	0.2%	0.7%	0.8%	2.5%	1.3%
EPS (Diluted)	$23.71	$51.55	$63.25	$9.10	$27.52	$36.00	$114.50	$54.33
EBITDA	$10.7B	$12.0B	$19.5B	$5.5B	$11.3B	$14.2B	$17.6B	$10.7B
Shares Outstanding	187M	187M	184M	183M	182M	182M	182M	182M

ALFRY OTC